Why Should You Attend:
Method validation is often cited in FDA inspectional observations, Warning Letter violations and reviewer comments regarding NDA and ANDA submissions. All analytical methods developed by pharmaceutical companies require method validation, as do any changes to compendia methods. Even if the compendia method is used unchanged, its suitability for the finished product in question should be demonstrated.
Selectivity, linearity, accuracy, precision, sensitivity, ruggedness and inter-analyst variability are among the method parameters that are measured during method validation.
Attend this webinar to understand each of the above parameter in details including the establishment of limits for determining whether the method passes this parameter. USP, FDA and other requirements for successful method validation will be presented.
Areas Covered in the Webinar:
Who Will Benefit:
Physical CD-DVD of recorded session will be despatched after 72 hrs on completion of payment
Recorded video session
Dr. Loren Gelber has more than 40 years of experience in pharmaceutical industry regulatory compliance. She worked for about 10 years at the FDA, including as a reviewer in the Division of Generic Drugs. She participated in the development of method validation requirements for HPLC analytical methods. She then transitions to industry, working for four different pharmaceutical companies. For the last 13 years she has been a regulatory compliance consultant, both for consulting companies and independently.